Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
Clinical trial NCT00846547 · COMPLETED
Trial details
- NCT number
- NCT00846547
- Sponsor
- Seaside Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-06-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.